BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 34881790)

  • 1. Vascular Endothelial (VE)-cadherin-mediated adherens junctions involvement in cardiovascular progenitor cell specification.
    Maltabe V; Kouklis P
    Int J Dev Biol; 2022; 66(1-2-3):77-83. PubMed ID: 34881790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-cadherin signaling via Trio assembles adherens junctions to restrict endothelial permeability.
    Kruse K; Lee QS; Sun Y; Klomp J; Yang X; Huang F; Sun MY; Zhao S; Hong Z; Vogel SM; Shin JW; Leckband DE; Tai LM; Malik AB; Komarova YA
    J Cell Biol; 2019 Jan; 218(1):299-316. PubMed ID: 30463880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. VE-CADHERIN is expressed transiently in early ISL1
    Maltabe VA; Melidoni AN; Beis D; Kokkinopoulos I; Paschalidis N; Kouklis P
    Stem Cell Reports; 2023 Sep; 18(9):1827-1840. PubMed ID: 37541259
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamics of vascular endothelial-cadherin and beta-catenin localization by vascular endothelial growth factor-induced angiogenesis in human umbilical vein cells.
    Wright TJ; Leach L; Shaw PE; Jones P
    Exp Cell Res; 2002 Nov; 280(2):159-68. PubMed ID: 12413882
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CMTM3 (CKLF-Like Marvel Transmembrane Domain 3) Mediates Angiogenesis by Regulating Cell Surface Availability of VE-Cadherin in Endothelial Adherens Junctions.
    Chrifi I; Louzao-Martinez L; Brandt M; van Dijk CGM; Burgisser P; Zhu C; Kros JM; Duncker DJ; Cheng C
    Arterioscler Thromb Vasc Biol; 2017 Jun; 37(6):1098-1114. PubMed ID: 28428220
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ubiquitin ligase CHFR mediated degradation of VE-cadherin through ubiquitylation disrupts endothelial adherens junctions.
    Tiruppathi C; Wang DM; Ansari MO; Bano S; Tsukasaki Y; Mukhopadhyay A; Joshi JC; Loch C; Niessen HWM; Malik AB
    Nat Commun; 2023 Oct; 14(1):6582. PubMed ID: 37852964
    [TBL] [Abstract][Full Text] [Related]  

  • 7. VE-PTP stabilizes VE-cadherin junctions and the endothelial barrier via a phosphatase-independent mechanism.
    Juettner VV; Kruse K; Dan A; Vu VH; Khan Y; Le J; Leckband D; Komarova Y; Malik AB
    J Cell Biol; 2019 May; 218(5):1725-1742. PubMed ID: 30948425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired activity of adherens junctions contributes to endothelial dilator dysfunction in ageing rat arteries.
    Chang F; Flavahan S; Flavahan NA
    J Physiol; 2017 Aug; 595(15):5143-5158. PubMed ID: 28561330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kruppel-like factor-4 transcriptionally regulates VE-cadherin expression and endothelial barrier function.
    Cowan CE; Kohler EE; Dugan TA; Mirza MK; Malik AB; Wary KK
    Circ Res; 2010 Oct; 107(8):959-66. PubMed ID: 20724706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CMTM4 regulates angiogenesis by promoting cell surface recycling of VE-cadherin to endothelial adherens junctions.
    Chrifi I; Louzao-Martinez L; Brandt MM; van Dijk CGM; Bürgisser PE; Zhu C; Kros JM; Verhaar MC; Duncker DJ; Cheng C
    Angiogenesis; 2019 Feb; 22(1):75-93. PubMed ID: 30097810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast growth factor signaling potentiates VE-cadherin stability at adherens junctions by regulating SHP2.
    Hatanaka K; Lanahan AA; Murakami M; Simons M
    PLoS One; 2012; 7(5):e37600. PubMed ID: 22629427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD93 maintains endothelial barrier function by limiting the phosphorylation and turnover of VE-cadherin.
    Lugano R; Vemuri K; Barbera S; Orlandini M; Dejana E; Claesson-Welsh L; Dimberg A
    FASEB J; 2023 Apr; 37(4):e22894. PubMed ID: 36961390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human mesenchymal stem cells inhibit vascular permeability by modulating vascular endothelial cadherin/β-catenin signaling.
    Pati S; Khakoo AY; Zhao J; Jimenez F; Gerber MH; Harting M; Redell JB; Grill R; Matsuo Y; Guha S; Cox CS; Reitz MS; Holcomb JB; Dash PK
    Stem Cells Dev; 2011 Jan; 20(1):89-101. PubMed ID: 20446815
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VE-cadherin signaling induces EB3 phosphorylation to suppress microtubule growth and assemble adherens junctions.
    Komarova YA; Huang F; Geyer M; Daneshjou N; Garcia A; Idalino L; Kreutz B; Mehta D; Malik AB
    Mol Cell; 2012 Dec; 48(6):914-25. PubMed ID: 23159740
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF2α signaling inhibits adherens junctional disruption in acute lung injury.
    Gong H; Rehman J; Tang H; Wary K; Mittal M; Chaturvedi P; Zhao YY; Komarova YA; Vogel SM; Malik AB
    J Clin Invest; 2015 Feb; 125(2):652-64. PubMed ID: 25574837
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anthrax lethal toxin-mediated disruption of endothelial VE-cadherin is attenuated by inhibition of the Rho-associated kinase pathway.
    Warfel JM; D'Agnillo F
    Toxins (Basel); 2011 Oct; 3(10):1278-93. PubMed ID: 22069696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophils induce sequential focal changes in endothelial adherens junction components: role of elastase.
    Ionescu CV; Cepinskas G; Savickiene J; Sandig M; Kvietys PR
    Microcirculation; 2003 Apr; 10(2):205-20. PubMed ID: 12700588
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of artificial and natural VE-cadherin-based adherens junctions.
    Taveau JC; Dubois M; Le Bihan O; Trépout S; Almagro S; Hewat E; Durmort C; Heyraud S; Gulino-Debrac D; Lambert O
    Biochem Soc Trans; 2008 Apr; 36(Pt 2):189-93. PubMed ID: 18363560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of adherens junctions and VE-cadherin in the control of vascular permeability.
    Dejana E; Orsenigo F; Lampugnani MG
    J Cell Sci; 2008 Jul; 121(Pt 13):2115-22. PubMed ID: 18565824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ischemic stroke activates the VE-cadherin promoter and increases VE-cadherin expression in adult mice.
    Nakano-Doi A; Sakuma R; Matsuyama T; Nakagomi T
    Histol Histopathol; 2018 May; 33(5):507-521. PubMed ID: 29205257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.